These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2964523)

  • 21. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
    Denora N; Potts BC; Stella VJ
    J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degradation kinetics and mechanisms of moricizine hydrochloride in acidic medium.
    King SP; Sigvardson KW; Dudzinski J; Torosian G
    J Pharm Sci; 1992 Jun; 81(6):586-91. PubMed ID: 1522500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation kinetics of (+/-)-4'-ethyl-2-methyl-3-(1-pyrrolidinyl)propiophenone hydrochloride (HY-770) and structure-stability relationship among its analogues in aqueous solution.
    Nagata O; Terasaki T; Yada E; Sato H; Tamai I; Tsuji A
    J Pharm Sci; 1989 Jan; 78(1):57-61. PubMed ID: 2709320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The aqueous stability of bupropion.
    O'Byrne PM; Williams R; Walsh JJ; Gilmer JF
    J Pharm Biomed Anal; 2010 Nov; 53(3):376-81. PubMed ID: 20547024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of hydrolysis of diltiazem hydrochloride in aqueous solutions.
    Muszalska I; Jamszoł L; Grześkowiak D
    Acta Pol Pharm; 2003; 60(3):163-8. PubMed ID: 14556482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation study of thiotepa in aqueous solutions.
    van Maanen MJ; Brandt AC; Damen JM; Beijnen JH
    Int J Pharm; 1999 Mar; 179(1):55-64. PubMed ID: 10053202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation kinetics of butylmethoxydibenzoylmethane (avobenzone) in aqueous solution.
    Mbah CJ
    Pharmazie; 2007 Oct; 62(10):747-9. PubMed ID: 18236778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of hydrolysis of 4-methoxy-2-[2-hydroxy-3(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine in aqueous solutions.
    Muszalska I
    Farmaco; 2004 Jun; 59(6):437-42. PubMed ID: 15178305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation kinetics and mechanism of aminocephalosporins in aqueous solution: cefadroxil.
    Tsuji A; Nakashima E; Deguchi Y; Nishide K; Shimizu T; Horiuchi S; Ishikawa K; Yamana T
    J Pharm Sci; 1981 Oct; 70(10):1120-8. PubMed ID: 7299645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The kinetics of the alkaline degradation of daptomycin.
    Muangsiri W; Kirsch LE
    J Pharm Sci; 2001 Aug; 90(8):1066-75. PubMed ID: 11536211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stability.
    Parasrampuria J; Gupta VD
    J Pharm Sci; 1989 Oct; 78(10):855-7. PubMed ID: 2600793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation kinetics of fluorouracil-acetic-acid-dextran conjugate in aqueous solution.
    Hao AJ; Deng YJ; Li TF; Suo XB; Cao YH; Hao YL; Zhang Y
    Drug Dev Ind Pharm; 2006 Jul; 32(6):757-63. PubMed ID: 16885130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics and mechanism of degradation of cefotaxime sodium in aqueous solution.
    Berge SM; Henderson NL; Frank MJ
    J Pharm Sci; 1983 Jan; 72(1):59-63. PubMed ID: 6298400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid): a potent antiinflammatory drug. Conformation and absolute configuration of its active enantiomer.
    Humber LG; Demerson CA; Swaminathan P; Bird PH
    J Med Chem; 1986 May; 29(5):871-4. PubMed ID: 2939246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide.
    Oliyai C; Borchardt RT
    Pharm Res; 1993 Jan; 10(1):95-102. PubMed ID: 8430066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics and mechanism of degradation of lithospermic acid B in aqueous solution.
    Guo YX; Xiu ZL; Zhang DJ; Wang H; Wang LX; Xiao HB
    J Pharm Biomed Anal; 2007 Mar; 43(4):1249-55. PubMed ID: 17118607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nefopam hydrochloride degradation kinetics in solution.
    Tu YH; Wang DP; Allen LV
    J Pharm Sci; 1990 Jan; 79(1):48-52. PubMed ID: 2313576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of hydroxypropyl-beta-cyclodextrin on the chemical stability of a naphthoquinone in aqueous solutions.
    Linares MS; Longhi MR
    Pharmazie; 2003 Jan; 58(1):32-7. PubMed ID: 12622250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degradation study of the investigational anticancer drug clanfenur.
    Sluiter C; Kettenes-van den Bosch JJ; Hop E; van der Houwen OA; Underberg WJ; Bult A
    Int J Pharm; 1999 Aug; 185(2):227-35. PubMed ID: 10460918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of pH and temperature on the degradation kinetics of 4-methoxy-2-[3-(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c] pyridine in aqueous solutions.
    Muszalska I; Wituła K
    Acta Pol Pharm; 2005; 62(2):83-8. PubMed ID: 16161346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.